Avalere Health
An Inovalon Company
Services

Federal & State Healthcare Policy

Predict Change

As the nation continues to struggle with improving outcomes, elevating quality, reducing costs, and driving value, federal and state policy activities remain core to making sound decisions for your business. Armed with policy experts and business strategists, Avalere guides organizations through the continued complexities of all aspects of healthcare public policy at both the federal and state levels. We help companies understand how changes to healthcare policy will affect coverage, access, payment, care delivery, and consumer choice. We partner with stakeholders from across the healthcare spectrum to help plan for insurance market reforms, Medicaid, Medicare Advantage, and Medicare Part D changes.

What's Your Challenge?

  • ​Policy Impact and Analysis
  • ​Policy Tracking and Monitoring
  • ​Comment Letters
  • ​Beneficiary Enrollment Trends

Complementary Products

Team

Meet a few of our experts ready to partner with you.

All Staff

Elizabeth Carpenter

Senior Vice President

Elizabeth
Carpenter

Elizabeth Carpenter, Senior Vice President, leads the Policy Practice at Avalere. Specifically, Elizabeth focuses on implementation of the Affordable Care Act, trends in commercial insurance, drug pricing policy, and the impact of politics on the policy landscape. 

Prior to joining Avalere, Elizabeth was a Senior Advisor in the Health Policy practice at McKenna Long & Aldridge LLP and the Associate Policy Director for the Health Policy Program at the New America Foundation. Previously, she served on both the legislative and campaign staffs of Senator Lincoln Chafee (RI).

Elizabeth has a BA in Political Science from Brown University.

Megan Olsen

Manager

Megan
Olsen

Megan Olsen, Manager, supports clients in anticipating and navigating the evolving federal and state health policy environment. In particular, she advises clients on their business and advocacy strategies related to legislative and regulatory developments. Megan has specific expertise in drug pricing policy, Medicaid, and health insurance markets, and she contributes to the firm’s analysis of Medicaid managed care trends. 

Prior to joining Avalere, Megan was a Public Policy Fellow with Novo Nordisk, where she assessed the impact of public policy developments to shape and support the company’s advocacy priorities. Megan previously interned at Avalere Health in the Health Reform practice, as well as with the New York State Department of Labor in the Research and Statistics Division.

Megan has an MPH in Health Policy from George Washington University’s Milken Institute School of Public Health and BA in Economics and Psychology from Saint Michael’s College. 

Cara Kelly

Vice President

Cara
Kelly

Cara Kelly, Vice President, advises clients on the impact of health reform initiatives, with an emphasis on health insurance exchanges and insurance market reforms. She specializes in helping health plans, pharmacy benefit managers and other healthcare stakeholders position strategically in the post-Affordable Care Act market. Cara also has expertise in Medicare Parts C and D.

Prior to rejoining Avalere, where she worked until 2010, Cara was at HHS’ Center for Consumer Information and Insurance Oversight (CCIIO). At CCIIO, she focused on Health Insurance Exchanges; specifically, she developed policy and operational requirements for qualified health plans and served as a technical expert for issuers, states and other stakeholders. She has particular knowledge about issues affecting health plans in State Partnership and Federally-facilitated Exchanges, including certification standards and processes, the essential health benefits package, and operational requirements. 

Cara has an MHS in Health Policy from Johns Hopkins University and a BA from Yale University. 

Gillian Woollett

Senior Vice President

Gillian
Woollett

Gillian Woollett, Senior Vice President, leads our FDA Practice. She provides the "prequel" of scientific and regulatory strategic policy expertise that supports medicinal products gaining approval at the FDA in a manner that allows them to be successful in the public and private reimbursement world. She is building a bridge for Avalere clients from the FDA space into the traditionally separate Centers for Medicare & Medicaid Services and healthcare policy/business world.

Prior to joining Avalere, Gillian was Chief Scientist at Engel & Novitt, LLP, and was Vice President, Science and Regulatory Affairs at the Biotechnology Industry Organization (BIO). She joined BIO after being Associate Vice President at the Pharmaceutical Research and Manufacturers of America. She has been an appointee on federal advisory committees to the CDC and the Department of Commerce. Trained as a molecular biologist/immunologist, Gillian publishes in peer-reviewed literature on biotechnology topics, and is a frequent speaker on emerging biosciences and their ability to support better and more focused therapies.

Gillian has a BA, MA in the Natural Sciences Tripos (Biochemistry) from the University of Cambridge, and a DPhil in Immunology from the University of Oxford.

« Back to Mobile Site